Exploring the Association of Hearing Loss with Diabetes Mellitus: A Critical Review

ABSTRACT

The prevalence of diabetes mellitus is quickly growing in the U.S. population, and among these individuals, many suffer from auditory impairment of increased severity compared with healthy individuals without diabetes. Clinical implications of diabetes mellitus and its affect on the auditory system have been widely recognized in the literature. This article reviews current evidence detailing the association between hearing loss and diabetes mellitus. Traditional and novel methods used in research of this association will be discussed, and descriptions for general audiological precautions for diabetic patients will be outlined. Although controversy exists in the literature, knowledge of the possible audiological aspects of the diabetic individual is paramount and exceedingly relevant to audiological practice as this population continues to increase. Continued research will provide further insight for which specific audiological management of these patients may be established.

Diabetes - type 1 diabetes - type 2 diabetes - hearing loss

REFERENCES

• 1 Centers for Disease Control and Prevention (CDC) .National diabetes fact sheet, 2011. National estimates and general information on diabetes and prediabetes in the United States. Available at: http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2011.pdf Accessed September 24, 2011
• 2 World Health Organization (WHO) .WHO Region of the Americas. 2010. Available at: http://www.who.int/diabetes/facts/world_figures/en/index3.html Accessed July 20, 2010
• 3 Centers for Disease Control and Prevention (CDC) .National diabetes fact sheet, 2007. General information and national estimates on diabetes in the United States. Available at: http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2007.pdf Accessed July 20, 2010
• 4 Pessin A B, Martins R H, Pimenta WdeP, Simões A C, Marsiglia A, Amaral A V. Auditory evaluation in patients with type 1 diabetes.  Ann Otol Rhinol Laryngol. 2008;  117 366-370
• 5 Lisowska G, Namysłowski G, Morawski K, Strojek K. Early identification of hearing impairment in patients with type 1 diabetes mellitus.  Otol Neurotol. 2001;  22 316-320
• 6 Bainbridge K E, Hoffman H J, Cowie C C. Diabetes and hearing impairment in the United States: audiometric evidence from the National Health and Nutrition Examination Survey, 1999 to 2004.  Ann Intern Med. 2008;  149 1-10
• 7 Frisina S T, Mapes F, Kim S, Frisina D R, Frisina R D. Characterization of hearing loss in aged type II diabetics.  Hear Res. 2006;  211 103-113
• 8 Lisowska G, Namysłowski G, Morawski K, Strojek K. Cochlear dysfunction and diabetic microangiopathy.  Scand Audiol Suppl. 2001;  (52) 199-203
• 9 Aladag I, Eyibilen A, Güven M, Atiş O, Erkokmaz U. Role of oxidative stress in hearing impairment in patients with type two diabetes mellitus.  J Laryngol Otol. 2009;  123 957-963
• 10 Ren J, Zhao P, Chen L, Xu A, Brown S N, Xiao X. Hearing loss in middle-aged subjects with type 2 diabetes mellitus.  Arch Med Res. 2009;  40 18-23
• 11 Kishore P. Diabetes mellitus. 2008. Available at: http://www.merckmanuals.com/home/hormonal_and_metabolic_disorders/diabetes_mellitus_dm/diabetes_mellitus.html?qt=kishore&alt=sh Accessed July 2, 2009
• 12 Saudek C, Rubin R, Shump C. The Johns Hopkins Guide to Diabetes for Today and Tomorrow. Baltimore, MD & London, UK: The Johns Hopkins University Press; 1997
• 13 Diniz T H, Guida H L. Hearing loss in patients with diabetes mellitus.  Braz J Otorhinolaryngol. 2009;  75 573-578
• 14 Taylor I G, Irwin J. Some audiological aspects of diabetes mellitus.  J Laryngol Otol. 1978;  92 99-113
• 15 Fukushima H, Cureoglu S, Schachern P A et al.. Cochlear changes in patients with type 1 diabetes mellitus.  Otolaryngol Head Neck Surg. 2005;  133 100-106
• 16 Fukushima H, Cureoglu S, Schachern P A, Paparella M M, Harada T, Oktay M F. Effects of type 2 diabetes mellitus on cochlear structure in humans.  Arch Otolaryngol Head Neck Surg. 2006;  132 934-938
• 17 Bayazit Y, Yilmaz M, Kepekçi Y, Mumbuç S, Kanlikama M. Use of the auditory brainstem response testing in the clinical evaluation of the patients with diabetes mellitus.  J Neurol Sci. 2000;  181 29-32
• 18 Díaz de León-Morales L V, Jáuregui-Renaud K, Garay-Sevilla M E, Hernández-Prado J, Malacara-Hernández J M. Auditory impairment in patients with type 2 diabetes mellitus.  Arch Med Res. 2005;  36 507-510
• 19 Vaughan N, James K, McDermott D, Griest S, Fausti S. Auditory brainstem response differences in diabetic and non-diabetic veterans.  J Am Acad Audiol. 2007;  18 863-871
• 20 Durmus C, Yetiser S, Durmus O. Auditory brainstem evoked responses in insulin-dependent (ID) and non-insulin-dependent (NID) diabetic subjects with normal hearing.  Int J Audiol. 2004;  43 29-33
• 21 Ottaviani F, Dozio N, Neglia C B, Riccio S, Scavini M. Absence of otoacoustic emissions in insulin-dependent diabetic patients: is there evidence for diabetic cochleopathy?.  J Diabetes Complications. 2002;  16 338-343
• 22 Loader B, Stokic D, Riedl M et al.. Combined analysis of audiologic performance and the plasma biomarker stromal cell-derived factor 1a in type 2 diabetic patients.  Otol Neurotol. 2008;  29 739-744
• 23 Austin D F, Konrad-Martin D, Griest S, McMillan G P, McDermott D, Fausti S. Diabetes-related changes in hearing.  Laryngoscope. 2009;  119 1788-1796
• 24 Agrawal Y, Platz E A, Niparko J K. Risk factors for hearing loss in US adults: data from the National Health and Nutrition Examination Survey, 1999 to 2002.  Otol Neurotol. 2009;  30 139-145
• 25 Padam A, Puri R, Sharma M L. Brainstem auditory evoked potential in diabetes mellitus.  Indian J Physiol Pharmacol. 2002;  46 375-378
• 26 Virtaniemi J, Kuusisto J, Karjalainen L, Karjalainen S, Laakso M. Improvement of metabolic control does not normalize auditory brainstem latencies in subjects with insulin-dependent diabetes mellitus.  Am J Otolaryngol. 1995;  16 172-176